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INGRID FELGER*
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Abstract. Parameters describing the infection dynamics of Plasmodium falciparum are important determinants of the
potential impact of interventions and are potential outcome measurements for malaria intervention trials. Low parasite
densities, periodic sequestration of parasites, and the presence of multiple concurrent infections make it essential to use
molecular techniques to estimate the force of infection and duration of infections in endemic areas. We now compare
two approaches for tracking individual genotypes of the highly polymorphic merozoite surface protein 2: 1) fluorescence-
labeled polymerase chain reaction (PCR) and GeneScan-sizing and 2) restriction fragment length polymorphism
(RFLP). We analyze samples from a longitudinal field study in Ghana and use statistical approaches that allow for
imperfect detectability. The two methods gave broadly similar estimates of parasite dynamics, but GeneScan is more
precise and can achieve a higher throughput. The analysis of parasite dynamics indicated an average duration of infection
of 210 days by GeneScan versus 152 days by PCR-RFLP in the study population in Kassena-Nankana, Northern Ghana.
This reflects the good performance of GeneScan-based genotyping for studies of parasite infection dynamics.
INTRODUCTION
Plasmodium falciparum parasite densities fluctuate over
time in the course of an infection, and the late stages of the
parasite cytoadhere to endothelial receptors and sequester in
deep tissues, leading to a 48-hour cycle in the appearance of
parasites in the peripheral circulation. These features of ma-
laria parasite biology complicate the analysis of infection dy-
namics. This background of persisting but transiently de-
tectible parasitemia makes it inappropriate to use standard
microscopy techniques to determine the rates of infection or
the clearance rates of infections in the absence of interven-
tions. These are essential parameters for understanding the
transmission dynamics of the parasite.1
Allelic discrimination is possible by molecular means and
multiple concurrent infections are usually found in blood
samples from areas endemic for malaria.2–4 Highly polymor-
phic marker genes amplified by polymerase chain reaction
(PCR) can be used to track individual clones in longitudinal
sample sets. Despite the lower detection limit of PCR relative
to microscopy, some clones still seem to disappear but are in
fact persisting, and genotyping often detects clones recurring
periodically at intervals of 48 hours.5,6 We have previously
analyzed infection dynamics of individual clones as deter-
mined by PCR-restriction fragment length polymorphism
(RFLP) using transition models based on the relative fre-
quencies of different patterns of infection defined by pres-
ence/absence at successive surveys.7,8 These models take into
account the imperfect detectability of clones sequestered at
the time of sampling.
We now compare two molecular techniques for identifying
individual clones. The first is RFLP of PCR fragments (PCR-
RFLP), which has been used in a number of studies to track
parasite clones longitudinally. The marker gene merozoite
surface protein 2 (msp2) is highly polymorphic because of
intragenic repeats, with > 50 genotypes identified by RFLP in
each of its two allelic families 3D7 and Fc27.3,9 The pattern of
restriction fragments clearly identifies individual clones, and
particular patterns are recognized also within mixed infec-
tions. However, in samples with more than five concurrent
genotypes, the superimposed patterns are increasingly more
difficult to analyze. The second technique is based on sizing
PCR fragments by an automated sequencer using the Gene-
Scan program. This technique uses fluorescent-labeled PCR
primers specific for the msp2 allelic families. FC27- and 3D7-
type msp2 PCR fragments are identified by the two fluores-
cent markers 6-Fam and VIC, respectively. The use of a dif-
ferent dye for each allelic family increases resolution of frag-
ment sizing. GeneScan analysis software uses a size standard
added to each sample after PCR to create an internal calibra-
tion curve to determine the size of each PCR fragment. In
comparison with PCR-RFLP, this technique increases
throughput and avoids subjectivity in analyzing the readout.
We report analyses of P. falciparum infections in 100 indi-
viduals of all ages from the Kassena-Nankana District (KND)
of Ghana sampled at 2-monthly intervals over 1 year. We
compare the performance of genotyping by PCR-RFLP ver-
sus GeneScan for the analysis of the force of infection (clonal
acquisition rate) and duration of individual infections based
on the patterns of persistence of individual genotypes.
MATERIALS AND METHODS
Study site and population. The population of KND in
northern Ghana is plagued by high infant and maternal mor-
tality rates.10 In KND, malaria transmission is seasonal, but
even in the absence of any rain, widespread transmission of
malaria continues. For a molecular epidemiologic survey of P.
falciparum multiplicity of infection and infections dynamics
among asymptomatic inhabitants of a holoendemic malarious
area, a cluster sample of the KND population was drawn by
selecting 16 index compounds at random from the 14,000
within the district. From each index compound, two people in
each of the following age categories were selected: < 1, 1–2,
3–4, 5–9, 10–19, 20–39, 40–59, and 60+ years. Blood samples
were collected on DNA ISOCode Stix (Schleicher & Schuell,
Dassel, Germany) in intervals of 2 months, resulting in a total
of six samples per participant (R1–R6). Blood samples for the
first time-point (R1) were collected in June/July 2000, and
genotyping results of R1 were presented previously.11 In-
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formed consent was obtained from participants by signature
or thumbprint in the presence of a witness. Ethical clearance
for this study was obtained from the Ghana Health Service
Ethics Committee. For this comparison of two genotyping
methods, a subset of the 1,848 samples collected were used,
amounting to 600 samples deriving from 100 individuals.
DNA isolation and genotyping. Whole blood (10 L) was
dotted onto ISOCode Stix. Irrespective of microscopy results,
six samples from each of 100 individuals were screened for
presence of P. falciparum by PCR. Processing of Stix, PCR
conditions, and RFLP procedures have been described in de-
tail.3,12 In brief, primary and nested PCR were performed for
RFLP analysis using primer pair S2/3 (5-GAAGGTAAT-
TAAAACATTGTC-3/ 5-GAGGGATGTTGCTGCTCC-
ACAG-3) and S1/4 (5-GAGTATAAGGAGAAGTATG-
3/5-CTAGAACCATGCATATGTCC-3), respectively, fol-
lowed by restriction digest with HinfI and DdeI as described
elsewhere.3,12
For GeneScan analysis, 2 L of primary PCR product was
amplified in nested PCR with the fluorescent-labeled family-
specific primer M5 (FC27-specific: 5-6-FAM-GCAT-
TGCCAGAACTTGAA-3) or N5 (3D7-specific: 5-VIC-
CTGAAGAGGTACTGGTAGA-3) at a concentration of
100 and 200 nM, respectively. The non-fluorescent–labeled
forward primer STail (5-CTTATAATATGAGTATAAG-
GAGAA-3) was modified at the 5 end by adding a 7-bp tail
to avoid non-template–directed addition of a single nucle-
otide to the 3 end of a blunt-end double-stranded DNA
(“plus-A-artefact”).13 The cycle conditions were 5 min at
94°C followed by 30 cycles of 30 s at 94°C, 1 min at 50°C, and
1 min at 70°C, and a final elongation for 7 min at 70°C.
nPCR product (0.5 L) was combined with 10 L ROX-
labeled size standard (diluted 1:10 with H2O to minimize pi-
petting errors). Samples were dried and sent to the Genomics
Core Laboratory of the MRC Clinical Science Center in Lon-
don. Highly deionized formamide was added, and after dena-
turation, samples were analyzed on an ABI PRISM 3700 ge-
netic analyzer.
Determination of detection limits. Genomic DNA was iso-
lated from P. falciparum in vitro cultures (FC27 and 3D7
strains) as described previously.14 DNA concentration was
determined photometrically. Tenfold dilutions of genomic
DNA were amplified in PCR reactions containing 1000, 100,
50, 10, 5, 1, and 0.1 genomes of either 3D7 or FC27 DNA or
a mixture of both.
Data analysis. An in-house–generated computer program
was used to process the output of the GeneScan analyzer. The
main tasks of this program were as follows: 1) Cut-off deter-
mination: a sample-specific cut-off was used to separate real
signals from noise and to allow for variability between
GeneScan runs. The cut-off was established by GeneScan
analysis of sequenced msp2 reference alleles (cloned msp2
fragments or single clone infections). The presence of a single
template per reaction made it possible to determine back-
ground fluorescence levels to 300 arbitrary fluorescence units.
A sample-specific cut-off was determined by multiplying the
arithmetic mean of peak heights of the size standard signals
per sample by a constant (the empirically chosen cut-off of
300 units divided by the mean peak height of size standard
peaks of all samples). Because with our primers none of the
msp2 sequences available at GenBank would give rise to a
PCR fragment of < 216 bp, peaks with a measured size of
< 200 bp were not considered. 2) Elimination of bleeding and
“plus-A-artifacts”: spectral overlap of the fluorescent dyes
labeling the family-specific primers caused bleeding in case of
strong signals caused by PCR fragments present at very high
concentrations (> 5,000 fluorescent units). Although the dyes
emit light at different wavelengths, some overlap exists de-
spite using a GeneScan software matrix file to remove spec-
tral overlaps. Taq polymerase has terminal deoxynucleotidyl
transferase activity to add an extra nucleotide, usually ad-
enine (“plus-A”), at the 3 end of PCR products. This results
in two populations of amplified products with a size differ-
ence of one nucleotide. Despite the use of a tailed primer that
supports “plus-A” addition, we observed in case of high in-
tensity peaks also a small peak about one nucleotide before
the actual peak. Our software eliminated peaks caused by
bleeding and “plus-A-artifact.” 3) Elimination of PCR arti-
facts: allele-specific PCR artifacts were detectable when par-
ticular alleles were present at a very high concentration. Such
artifacts are likely caused by the intragenic repeats of msp2
alleles, which can facilitate aberrant annealing of an incom-
pletely synthesized strand to the repeat region. We deter-
mined allele-specific PCR artifacts by analyzing cloned msp2
alleles at high DNA concentrations. Artifacts were omitted
from subsequent analyses. 4) Genotype calling: For analysis
of longitudinal sets of samples, a persisting genotype must be
accurately identified in sequential blood samples. There were
slight variations among repeated size determinations of iden-
tical fragments depending on the concentration of the ampli-
fied fragment. To allow for inaccuracies in size determination,
peaks were assigned to size bins with a width of 2.4 bp. Be-
cause a coding region is genotyped, fragment sizes must differ
by multiples of 3 bp.
Statistical analysis. For comparing the two genotyping
methods, SAS statistical software Release 8.2 (SAS Institute,
Cary, NC) was used. Infection dynamics were analyzed by
calculating the frequency of gains, losses, and persistence of
infecting clones. An infection present in survey at time t, but
not seen in the subsequent survey t + 1 was considered as
“loss” (+ −), whereas “gain” (− +) was noted when an infec-
tion was observed in round t but not in the previous round t
− 1. Where infections were observed in consecutive surveys
this was recorded as “persistence.”
We analyzed the infection dynamics using methods that
allow for imperfect detection using the method of Smith et
al.7 In further analysis, we fitted an immigration-death model
to the full sequences of six observations.8 This provided esti-
mates of the rate of new infection, , clearance rate, , and
detectability.
RESULTS
Limit of detection and evaluation of GeneScan. Serial di-
lutions of genomic DNA from parasite culture strains FC27
and 3D7 were prepared to determine the detection limit of
GeneScan-based msp2 genotyping. After primary PCR,
nested PCR was performed either independently for each
primer set (3D7 simplex PCR and FC27 simplex PCR) or with
a combination of FC27- and 3D7-specific primers (duplex
PCR). While both the FC27-and 3D7-specific simplex PCR
detected one parasite genome per reaction, performing a du-
plex PCR with equal amounts of both templates reduced the
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detection limit to 5 genomes per reaction (Table 1). This
sensitivity was considered sufficient and considerably reduced
costs justified duplex PCR for field samples.
The effect of excess DNA of the alternative allelic family
was assessed for duplex PCR. 3D7-specific amplification re-
mained unaffected by the presence of 1000 FC27 genomes.
However, FC27-specific amplification detected only 10 ge-
nomes in the presence of 1000 3D7 genomes. This difference
is probably caused by the smaller amplicon size of 3D7 (267 bp)
versus FC27 (358 bp; accession numbers M28891 and J03828).
Before application to field samples, the technique was vali-
dated on a panel of sequenced reference alleles (data not
shown). The SD of repeated sizing of the same fragment was
only about 0.06 and 0.17 nucleotides for FC27 and 3D7 DNA,
respectively. For the most frequent allele in the Ghanaian
field samples, an SD of 0.14 was calculated.
When comparing all msp2 sequences submitted to Gen-
Bank until 2004, we detected two genotype pairs of the same
allelic family sharing the same amplicon size (accession num-
bers U07001/U16842 and AY534506/AF010461). Thus, Gene-
Scan cannot discriminate these alleles. This represents the
limitation of our method.
Longitudinal genotyping in field samples from Ghana. From
100 individuals enrolled at baseline, 550 blood samples were
collected during the 1-year follow-up in 2-monthly intervals;
78.2% were found to be positive for P. falciparum by PCR.
For 99 individuals, GeneScan analysis was successfully per-
formed, and 96 individuals were analyzed by PCR-RFLP, ac-
counting for 1,405 and 1,084 observed clonal infections, re-
spectively. The discrepancy is caused by differences in the
resolution of these methods. Problems occurred in particular
with the PCR-RFLP method when interpreting superimposed
RFLP patterns.
A total of 164 different msp2 alleles were distinguished by
GeneScan analysis; 116 and 48 belonged to the 3D7 and FC27
allelic family, respectively. Frequencies of 3D7-type alleles
were all < 3% (Figure 1a). Some FC27-alleles occurred at
very high allelic frequencies, the most frequent one reaching
14% (Figure 1b).
Multiplicity of infection. Overall multiplicity of infection
(MOI) assessed by GeneScan was higher than by PCR-RFLP
with a mean multiplicity of 6.6 (95% CI: 5.6–7.6) in age group
5–9 years, whereas RFLP analysis only detected a mean of 5.0
(95% CI: 4.5–5.5) infections. The age trends were similar with
the two methods, with average MOI increasing until the age
of 5–9 and decreasing during adolescence and adulthood (Fig-
ure 2a). Mean multiplicity in each age group was analyzed
separately for 3D7- and FC27-type alleles (Figure 2, b and c).
3D7-type infections were more frequent in all age groups than
FC27-type infections.
Infection dynamics. To describe the longitudinal genotyp-
ing data, we determined the numbers of transitions between
genotypes of consecutive samples (Table 2). A transition is
either a loss of a genotype or a gain (depicted as patterns +
−and − +, respectively). When comparing both genotyping
methods, a similar age distribution of transitions (Figure 3, a
and b) was found. For both methods, the gain of new infec-
tions was highest in children aged 5–9. The loss of infection
was highest in people > 60 years of age, and the persistence of
infecting clones was less frequent in older age groups.
The pattern of gains and losses of genotypes over the
course of the 12 months of the study exhibited seasonal varia-
tion (Figure 4). The number of gains was highest in the first to
second survey, reflecting the higher transmission rate during
the wet season. Gains became gradually less frequent in the
following surveys. Loss and persistence rates remained un-
changed throughout the year. Comparison of both genotyping
methods showed that new alleles (gain – +) were more fre-
quently detected by GeneScan than by RLFP. The number of
losses was slightly higher in samples analyzed with RFLP.
Statistical analysis and modeling. The above description of
simple transitions does not take into account the imperfect
TABLE 1
Sensitivity of detection of msp2 PCT fragments by agarose gel electrophoresis compared to GeneScan (GS)
Number of templates/reaction* 1000 100 50 10 5 1 0.1
Detection technique Gel GS Gel GS Gel GS Gel GS Gel GS Gel GS Gel GS
Fc27 amplified in simplex PCR + + + + nd nd + + + + + + − −
3D7 amplified in simplex PCR + + + + nd nd + + + + − + − −
Fc27 amplified in duplex PCR + + + + nd nd + + + + − − − −
3D7 amplified in duplex PCR + + + + nd nd + + + + − − − −
Fc27 in presence of 1000 3D7 copies + + + + + + − + − − − − − −
3D7 in presence of 1000 Fc27 copies + + + + + + + + + + − − − −
* One template corresponds to one genome of a FC27 or 3D7 parasite from an in vitro culture.
TABLE 2
Frequencies of transition by allelic family assessed by GeneScan and RFLP
Family
Number of
intervals
Gain Loss Persistence
Number of
transitions
Gains per
interval
Number of
transitions
Percent of
possible losses
Number of
transitions
Percent of
possible losses
GeneScan
3D7 418 820 1.96 891 80.3% 218 19.7%
FC27 418 360 0.86 370 59.4% 253 40.6%
RFLP
3D7 406 600 1.477833 616 83.5% 122 16.5%
FC27 406 323 0.795567 314 48.2% 338 51.8%
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detection of sequestered parasite clones. Statistical models
can be applied to estimate the true presence and the actual
persistence of genotypes.1,8 While paired samples do not al-
low identification of the detectability (the detected propor-
tion of all genotypes actually present), this can be estimated
from sequences of three or more consecutive samples from
the same individual. We analyzed our data according to an
approach proposed by Sama and others,8 making use of an
immigration death model. Immigration refers to the acquisi-
tion of a new parasitic genotype with rate , and death refers
to the clearance of a parasitic genotype with rate . The
model assumes that corresponding to each observed process
that is the detection or failure to detect a parasitic genotype is
an underlying true process, which is hidden as a result of
imperfect detection by the parasitological diagnostic tool
(GeneScan or RFLP). For GeneScan, this approach estimates
a detectability of 0.35 (95% CI: 0.31–0.39) that is an average
of 35% of the parasite present in the host are detected in a
finger-prick blood sample. For RFLP, the detectability was
0.47 (0.42–0.51). This estimation of the detectability was also
done based on a simpler approach,7 which led to comparable
results (data not shown).
Based on the genotype acquisition and clearance rates 
and , respectively, we determined the average duration of an
infection. We estimated a value of 19.6 (17.3–22.0) per year
for  and 1.7 (1.4–2.1) per year for , which corresponds to an
average duration of infection of 210 (176–256) days when
samples were analyzed by GeneScan. For RFLP analysis, 
and  were found to be 16.3 (14.8–18.0) and 2.4 (2.1–2.7),
respectively, which corresponds to an average duration of
infection of 152 (133–177) days. Our comparison of both
genotyping techniques and both statistical approaches
showed that the turnover rate for 3D7- type alleles was almost
twice as high as for the FC27-type alleles and that infections
with FC27-type alleles persisted longer.
DISCUSSION
The P. falciparum msp2 gene is highly polymorphic and
therefore qualifies as an ideal marker gene for analysis of
parasite dynamics. The PCR-RFLP genotyping technique has
been applied in many descriptive and analytical studies.15–18
GeneScan-based msp2 genotyping overcomes some limita-
tions of PCR-RFLP. The major advantage lies in the accuracy
of identifying particular genotypes in complex mixtures and in
different samples. Misclassification of the allelic family is pre-
vented by using fluorescently labeled primers, allele frequen-
cies can be determined precisely, and throughput is increased
considerably. Alternative genotyping approaches were also
based on discrimination of amplicon size, but genotypes rep-
resented discrete bins, spanning 20 nucleotides and compris-
ing several alleles of similar size.19,20 For some loci, this iden-
tifies only a few alleles, making it necessary to use statistical
models to estimate allele frequencies.21 Our new methodol-
FIGURE 1. Frequencies of 164 different msp2 genotypes detected by GeneScan in six 2-monthly surveys of 99 individuals from Ghana (total
number of parasite clones detected N  1,405). (a) Genotypes belonging to the 3D7 allelic family (N  116). (b) FC27-type genotypes (N  48).
FIGURE 2. Age dependency of mean multiplicity. (a) Overall mul-
tiplicity assessed by GeneScan and PCR-RFLP. (b) 3D7-type msp2
alleles. (c) FC27-type msp2 alleles.
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ogy produces precise genotype frequencies that are essential
to estimate the rate of reinfection with the same genotype.
In our study, we investigated several parameters: MOI by
age, different transition states by allelic family, and seasonal
effects on these transitions. In both data sets, mean MOI was
low among infants, increased steadily until 5–9 years, and
started to decrease again during adulthood. This finding is
consistent with the previously published cross-sectional re-
sults from the first survey.11 The distribution of the three
transition types (gain, loss, and persistence of clones) was
similar in both methods, with acquisition of infections being
most frequent within the first and second transition interval,
reflecting the increase in transmission rate during the second
half of the wet season. The number of transitions, however,
was different between the two laboratory methods. By Gene-
Scan, more genotypes were gained, whereas by PCR-RFLP,
the clearance rate was higher. Both these findings might be
caused by higher sensitivity of GeneScan. In particular, 3D7-
type alleles are difficult to determine in polyacrylamide gels
used for PCR-RFLP but easy to identify by using family-
specific fluorescent primers in GeneScan analysis, resulting in
a higher number of acquisitions. The higher percentage of
losses by PCR-RFLP can also be explained by higher sensi-
tivity of GeneScan, because the transition pattern + − − by
RFLP analysis was found to be + − + by GeneScan.
Another parameter calculated from transition rates was the
duration of infections. The turnover rate of 3D7 infections
was higher in both data sets. This suggests that FC27 alleles
are more stable over time and more resistant to elimination
under selective pressure by the host’s immune system than
3D7 alleles.
Sensitivity and detectability. The sensitivity of PCR-RFLP
versus the GeneScan technique and their performance in a
molecular epidemiologic field study can be compared by the
total number of parasite clones detected by each technique.
Compared with PCR-RFLP, we found an increase by 22.8%
for GeneScan-based genotyping. This is also reflected by the
parameter “mean MOI,” which by GeneScan showed an in-
crease of 1.6 infections at the peak of the age distribution. We
found that the increased sensitivity in field samples was
caused by higher precision in discriminating 3D7-type geno-
types. This can be explained by the scrambled repeat struc-
ture of 3D7-type alleles, giving rise to only small differences
in fragment sizes that can hardly be discriminated by PCR-
FIGURE 3. Number of newly acquired, lost, or persisting infections per person-interval by age group, determined with (a) RFLP and (b)
GeneScan.
FIGURE 4. Frequencies of transition types by survey interval determined by (a) RFLP or (b) GeneScan.
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RFLP in gel electrophoresis. We conclude that the increase in
detected clones by GeneScan typing was accounted for by
problems of PCR-RFLP in resolving the complex 3D7-type
patterns in multiple infections.
Even optimal sensitivity of P. falciparum detection does
not reflect the whole parasite population in an infected indi-
vidual. Sequestration of late stage parasites causes a 48-hour
periodicity in detectability. Such fluctuations were observed
when monitoring the daily dynamics of P. falciparum clones.5
Thus, imperfect detection of some of the P. falciparum clones
concurrently present in a host is a consequence of the para-
site’s life cycle, and the estimation of persistence is compli-
cated even using molecular methods. Therefore, mathemati-
cal models need to be applied to estimate the molecular pa-
rameters based on such imperfect data.
Both the approaches we used7,8 take into account the fre-
quencies of transitions. A substantial frequency of the pattern
{+ − +} indicates imperfect detection. The detectability is our
estimate of that proportion of the duration of an infection
during which the densities are high enough to be detected,
averaged over all the infections known to be present. Para-
doxically, we found a lower detectability by GeneScan (35%)
than by PCR-RFLP (47%), despite the fact that GeneScan
had detected more genotypes. We arrived at the same con-
clusion when the method of Smith et al.7 was used. This can
be explained by different detection limits. Figure 5 shows the
density profile of three hypothetical infections. Curve A rep-
resents an infection that persists at detectable density and is
detected in almost the same proportion by both techniques.
Curve B represents an infection that occasionally reaches de-
tectable density, but persists sub-patently for a long time. A
proportion of such infections is detected by GeneScan, but
not by RFLP. Curve C represents an infection that persists for
a short time and is also more likely to be detected by Gene-
Scan. It is likely that patterns B and C contribute to a reduced
overall estimate of GeneScan detectability compared with
RFLP, which never sees infections such as B or C.
Relevance of molecular parameters. The molecular param-
eters we have used to describe multiple P. falciparum infec-
tions longitudinally can give new insights in malaria epidemi-
ology. The force of infection can be studied with respect to
age, seasonal variation, or as an effect of an intervention.
Also, the duration of infections in endemic areas can only be
estimated by molecular means because of frequent superin-
fection. Effects of interventions on duration of infections can
provide a valuable outcome measurement.
The potential of GeneScan-based msp2 genotyping has re-
cently been shown for the discrimination of recrudescent
from new infections in drug efficacy studies.22 We anticipate
further applications of molecular parameters in a range of
intervention studies against malaria.23 In malaria vaccine tri-
als, molecular monitoring has been applied to detect selective
effects if the vaccine was polymorphic.17,24 Molecular infec-
tion dynamics parameters could further contribute to describe
the parasitological outcomes of vaccine trials and perhaps
elucidate biologic effects of candidate vaccines.
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